Stockscreener 앱 받기
3.25
6.84%
-0.26
전일 마감가:
$3.51
열려 있는:
$3.53
하루 거래량:
71,652
Relative Volume:
0.05
시가총액:
$5.67M
수익:
$12.31M
순이익/손실:
$-5.08M
주가수익비율:
-3.4574
EPS:
-0.94
순현금흐름:
$-5.20M
1주 성능:
+52.80%
1개월 성능:
+24.81%
6개월 성능:
-6.57%
1년 성능:
+19.34%
1일 변동 폭
$3.25
$3.53
1주일 범위
$1.90
$4.46
52주 변동 폭
$1.90
$9.374
소노마 파머 Stock (SNOA) Company Profile
명칭
Sonoma Pharmaceuticals Inc
전화
800-759-9305
주소
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
SNOA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
3.255 | 5.67M | 12.31M | -5.08M | -5.20M | -0.94 |
|
ZTS
Zoetis Inc
|
160.64 | 72.40B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.09 | 47.12B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.11 | 46.08B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.25 | 18.88B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.28 | 13.96B | 612.78M | -86.37M | -62.91M | -0.87 |
소노마 파머 주식(SNOA)의 최신 뉴스
Scar Management Market Top PlayersNewmedical Technology - openPR
Why Fast-paced Mover Sonoma Pharmaceuticals (SNOA) Is a Great Choice for Value Investors - Yahoo Finance
SNOA's Wound Care Products Get Regulatory Clearance, LFMD's Q4 Revenue Soars, ATRA On Watch - RTTNews
Sonoma Pharmaceuticals expands into UK market By Investing.com - Investing.com Australia
Sonoma Pharmaceuticals expands into UK market - Investing.com India
Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA) - ACCESS Newswire
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket - Benzinga
Market Cool On Sonoma Pharmaceuticals, Inc.'s (NASDAQ:SNOA) Revenues Pushing Shares 25% Lower - Simply Wall St
SNOA stock touches 52-week low at $2 amid market challenges - Investing.com Australia
SNOA stock touches 52-week low at $2 amid market challenges By Investing.com - Investing.com South Africa
Sonoma Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Scar Treatment Market Projected To Witness Massive Growth, - openPR
Addex Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ADXN - Benzinga
Virpax Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:VRPX - Benzinga
Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff - ACCESS Newswire
SNOA Stock Touches 52-Week Low at $2.29 Amid Market Challenges By Investing.com - Investing.com South Africa
SNOA Stock Touches 52-Week Low at $2.29 Amid Market Challenges - Investing.com
Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando - ACCESS Newswire
How Sonoma Pharmaceuticals Plans to Expand Its Dermatology Footprint at Major 2025 Industry Event - StockTitan
Investor Network: Sonoma Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Sonoma Pharmaceuticals secures new supply agreement - MSN
SNOA stock touches 52-week low at $2.44 amid market challenges - Investing.com Canada
Sonoma County earmarks opioid settlement money for treatment, education programs - MSN
More Musk-like 'Dexits' pose fresh threat to Delaware's corporation crown - Yahoo Finance
CNS Pharma (NASDAQ:CNSP) Stock Quotes, Forecast and News Summary - Benzinga
Head-To-Head Survey: Sonoma Pharmaceuticals (NASDAQ:SNOA) and BrainsWay (NASDAQ:BWAY) - Defense World
Redhill Biopharma (NASDAQ:RDHL) Stock Quotes, Forecast and News Summary - Benzinga
Head-To-Head Survey: Sonoma Pharmaceuticals (NASDAQ:SNOA) vs. Femasys (NASDAQ:FEMY) - Defense World
Keloid Treatment Market in 2022: Forecast to Reach $4.72 Bn by 2031. - openPR
Is Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Worth US$2.7 Based On Its Intrinsic Value? - Yahoo Finance
Sonoma Pharmaceuticals (SNOA) to Release Quarterly Earnings on Thursday - Defense World
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 - Marketscreener.com
Sonoma Pharmaceuticals Inc. (SNOA) reports earnings - Quartz
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results - ACCESS Newswire
Earnings Alert: Sonoma Pharma Delivers Double-Digit Growth, Secures Major Distribution Deals - StockTitan
Sonoma Pharmaceuticals (NASDAQ:SNOA) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Sonoma Pharmaceuticals secures new supply agreement By Investing.com - Investing.com Canada
Dental Market Future Business Opportunities 2025-2032 | - openPR
Hypertrophic And Keloid Scar Treatment Global Market Expected To Ascend to $12.51 Billion By 2029 - WhaTech
Sonoma Pharmaceuticals (SNOA) Stock Surges Amid Industry Decline - GuruFocus.com
Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences - ACCESS Newswire
Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI Conference in Frankfurt, Germany - ACCESS Newswire
Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores - ACCESS Newswire
Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea - ACCESS Newswire
Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections - ACCESS Newswire
소노마 파머 (SNOA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.73%
0.82%
자본화:
|
볼륨(24시간):